InvestorsHub Logo
Followers 63
Posts 1756
Boards Moderated 0
Alias Born 09/21/2016

Re: XenaLives post# 205168

Thursday, 08/08/2019 6:25:59 AM

Thursday, August 08, 2019 6:25:59 AM

Post# of 458787
Xena,

It could. On the other hand, Missling seemed to indicate on CC yesterday that he would like to get this (Blarc) to market asap - they even have a marketing team working on a company chosen commercial name for the drug - great!!

That being said, no matter how long the AD trial takes, if/when approval for Rett or PDD - off label use will take place. This is another great reason for the MOA paper - it will establish that Blarc is versatile across a much broader spectrum of indications and the method and extent to which it would have a strong impact on these and therefore it would read like a “Merck Manual” of drugs and their prescribing for pertinent indications. All imo.

Bio

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News